Acupuncture for pain and osteoarthritis of the knee: a pilot study for an open parallel-arm randomised controlled trial by Lansdown, Harriet et al.
BioMed  Central
Page 1 of 13
(page number not for citation purposes)
BMC Musculoskeletal Disorders
Open Access Research article
Acupuncture for pain and osteoarthritis of the knee: a pilot study 
for an open parallel-arm randomised controlled trial
Harriet Lansdown1, Katie Howard1, Stephen Brealey1 and 
Hugh MacPherson*1,2
Address: 1Department of Health Sciences, University of York, York, UK and 2Foundation for Research into Traditional Chinese Medicine, York, UK
Email: Harriet Lansdown - harrietlansdown@gmail.com; Katie Howard - katiedrawoh@hotmail.co.uk; Stephen Brealey - sb143@york.ac.uk; 
Hugh MacPherson* - hm18@york.ac.uk
* Corresponding author    
Abstract
Background: There is some evidence that acupuncture for pain and osteoarthritis (OA) of the
knee is more than a placebo, and short term clinical benefits have been observed when acupuncture
is compared to usual care. However there is insufficient evidence on whether clinical benefits of
acupuncture are sustained over the longer term. In this study our key objectives are to inform the
design parameters for a fully powered pragmatic randomised controlled trial. These objectives
include establishing potential recruitment rates, appropriate validated outcome measures,
attendance levels for acupuncture treatment, loss to follow up and the sample size for a full scale
trial.
Methods: Potential participants aged over 50 with pain and osteoarthritis of the knee were
identified from a GP database. Eligible patients were randomised to either 'acupuncture plus usual
care' and 'usual care' alone, with allocation appropriately concealed. Acupuncture consisted of up
to 10 sessions usually weekly. Outcome measures included Western Ontario and McMaster
Universities (WOMAC) index with the sample size for a full scale trial determined from the
variance.
Results: From the GP database of 15,927 patients, 335 potential trial participants were identified
and invited to participate. After screening responses, 78 (23%) were identified as eligible and 30
patients who responded most promptly were randomised to 'acupuncture plus usual care' (15
patients) and 'usual care' alone (15 patients). Attendance for acupuncture appointments was high
at 90% of the maximum. Although the trial was not powered to detect significant changes in
outcome, the WOMAC pain index showed a statistically significant reduction at 3 months in the
acupuncture group compared to usual care. This was not sustained at 12 months. The sample size
for a fully powered two-arm trial was estimated to be 350.
Conclusion: This pilot study provided the evidence that a fully powered study to explore the
longer term impact of acupuncture would be worthwhile, and relevant design features for such a
trial were determined.
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Background
Pain and osteoarthritis (OA) of the knee are accompanied
with varying degrees of functional limitation and reduced
quality of life[1] In adults aged 45 years and over, the
most common site of peripheral joint pain is in the knee
and the highest prevalence of knee pain is amongst
women aged 75 and over[2] Established risk factors for
knee OA include obesity, age, female gender, misalign-
ment, and knee injury [3-5] Osteoarthritis of the knee is a
serious and chronic condition. In an increasingly ageing
and obese population, the prevalence and incidence of
OA of the knee is predicted to rise[6]
Patients may present with symptoms of pain and stiffness,
joint instability, crepitus, decreased function and mobil-
ity. Diagnosis is commonly made clinically in primary
care, and may be confirmed by radiological tests. The
mainstay of conventional treatment includes analgesia,
physiotherapy and joint replacement if indicated. Whilst
osteoarthritis has often been considered as progressive
and incurable,[7] the disease has also been viewed as a
metabolically dynamic, essentially reparative process that
is potentially amenable to treatment[8]
Three recent high quality meta-analyses of pooled data
from randomised controlled trials of acupuncture treat-
ment for osteoarthritis of the knee provide consistent evi-
dence that acupuncture is more effective than sham
acupuncture when patients are blinded to the interven-
tion they received [9-11]. For example in one review, Man-
heimer et al found effect sizes ranged between 0.35 (95%
CI: 0.15 to 0.55) for short term outcomes and 0.13 (95%
CI: 0.01 to 0.24) for long term outcomes[10] Only one of
the three reviews pooled data comparing acupuncture to
usual care alone in which patients were unblinded. For
this comparison, statistically significant differences were
again found but with larger effect sizes of 0.62 (95% CI:
0.49 to 0.75) for short term outcomes (up to 3 months)
and 0.52 (95% CI: 0.39 to 0.66) for longer term outcomes
(at 6 months)[10] It may be counter-intuitive that effect
sizes were larger when acupuncture was compared to
usual care (an active comparator), however it is consistent
with findings across the field that sham acupuncture tends
to be highly therapeutic[12] Despite this emerging data,
the UK National Institute for Health and Clinical Excel-
lence (NICE) guidelines published subsequently state
that, "There is not enough consistent evidence of clinical
or cost-effectiveness to allow a firm recommendation for
the use of acupuncture for the treatment of osteoarthri-
tis."[1]
There are a number of limitations to the existing evidence.
Firstly, none of the studies answered the pragmatic ques-
tion about the effectiveness of acupuncture as an adjunc-
tive treatment to usual primary care as delivered in the
UK. A second problem is that most trials tended to have
short-term follow-ups, typically no more than 26 weeks,
more commonly as little as a month. While significant
longer-term effects of acupuncture when compared to
usual care have been shown for headache over 12
months,[13] and for low back pain over 24 months,[14]
there is inconclusive evidence of longer term benefits of
acupuncture for osteoarthritis of the knee. Thirdly the evi-
dence on cost-effectiveness is limited, with trial data from
Germany,[15] but no trial data relevant to the UK con-
text[1] The combination of these limitations makes it dif-
ficult to estimate health service benefits and costs that
need to be considered as part of a NHS decision process.
Given the challenges of treating osteoarthritis of the knee,
the NICE guidelines have clearly identified the need for
further studies to evaluate non-pharmacological therapies
with a focus evaluating longer-term and sustained clinical
effects as well as cost-effectiveness[1] NICE guidelines
have also identified the need concurrently to address
quality of life issues and comorbid conditions that com-
pound the effect of osteoarthritis[1] It is in this context
that we have designed a pilot study to identify the key
design features necessary for a full scale randomised con-
trol trial. Our key objectives were to establish potential
recruitment rate, appropriate validated outcome meas-
ures, attendance levels for acupuncture treatment, loss to
follow up and the sample size for a full scale trial.
Methods
Design
We conducted a pragmatic parallel two-armed rand-
omized control trial (RCT) comparing 'acupuncture and
usual care' to 'usual care' alone. This was a Phase II study
based on the methodology set out in the Medical Research
Council's guidelines for the evaluation of complex inter-
ventions[16] The pragmatic design builds on current evi-
dence that there is a significant difference between
acupuncture and sham acupuncture for this condition [9-
11]. It addresses practical research questions raised by
NICE regarding clinical and cost effectiveness in an NHS
context[1] In practical terms this pragmatic trial design
offers best value by providing clinical results that are
immediately applicable to patients and providers. The
cost- effectiveness data, based on a real-world comparison
will aid policy and decision-makers.
Participant Recruitment and Randomization
Participants were recruited from a York-based GP practice
with a list size of 15,927 patients. A search of their data-
base identified patients over 50 years old who had con-
sulted their GP in the last 3 years with knee pain, using the
READ codes of 'knee pain', 'knee joint pain', 'osteoarthri-
tis of the knee', 'anterior knee pain', 'other knee injury',
'painful right knee' and 'arthralgia'. These classificationsBMC Musculoskeletal Disorders 2009, 10:130 http://www.biomedcentral.com/1471-2474/10/130
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were used to capture the wider population of patients with
clinical symptoms of OA of the knee, but no radiographi-
cally confirmed diagnosis[17] These patients were sent an
information leaflet, consent form and a screening ques-
tionnaire. Patients were recruited if they reported experi-
encing ongoing pain and stiffness in their knee, but were
not under cancer care review, currently receiving acupunc-
ture, having had a knee or hip replacement, involved in
any insurance claim or litigation related to their knee
pain, or suffering from rheumatoid arthritis or haemo-
philia. Recruited patients were randomised by the York
Trials Unit using a computer-generated (STATA) random
allocation method. As participants were enrolled their
pre-randomisation number was emailed to the Unit, and
their post-randomisation number and the group alloca-
tion to emailed back by return. This ensured that the per-
son recruiting participants was different from the person
implementing the allocation sequence in accordance with
CONSORT guidelines[18] The study gained ethical
approval from the York Local Research Ethics Committee
on the 6th June 2006 (ref: 06/Q1108/30).
Outcome measures
Our primary outcomes are to establish the patient recruit-
ment rate, appropriate validated outcome measures,
attendance levels for acupuncture treatment, loss to fol-
low up and the sample size for a full-scale trial. Our clini-
cal outcomes included the Western Ontario and
McMaster's University Osteoarthritis Index
(WOMAC)[19], Oxford Knee Score (OKS)[20], SF36 ver-
sion 2[21] and EQ-5D[22] The WOMAC is used to meas-
ure dimensions of pain, stiffness and function in knee and
hip osteoarthritis, and the higher the score the more
severe impairment. The OKS is designed to measure func-
tion and pain and total score. A lower score indicates a
better state of health. The SF36 and EQ5D were used to
measure health status and quality of life with higher
scores indicating a better level of functioning. All data
were collected by post at baseline, and 1, 3 and 12 months
post randomisation, with reminders sent out as necessary
for the first two of these follow-ups.
Intervention
Patients allocated to the acupuncture treatment group
were referred to one of 5 acupuncturists who were mem-
bers of the British Acupuncture Council (BAcC), with a
minimum training of three years full-time and at least
three years post qualification experience. Acupuncture
practitioners were advised they could see these patients
for up to 10 treatments as necessary. The participating acu-
puncturists agreed to follow an adapted protocol devel-
oped for the treatment of depression[23], with a focus on
the use of clinical judgment drawing on a specified range
of theoretical frameworks This flexible approach meant
that the numbers of needles inserted, depth of needle
insertion, needle responses elicited, needle stimulation
used, needle retention time and needle type varied. Treat-
ments were usually weekly and key treatment details were
recorded in a treatment log, including theoretical frame-
works, acu-points used, and any additional components
of treatment provided. Adverse events reported by
patients to practitioners were recorded after each treat-
ment.
Both groups received 'usual care', which included any
appointments, medications (prescribed or over the coun-
ter) and interventions sought by participants from any
health practitioner. Data on all usual care treatments
received by both groups were collected using follow-up
postal questionnaires at 3 and 12 months.
Statistical analysis
Using SPSS version 15, data were analysed on an inten-
tion to treat basis. A regression model, with baseline out-
come measure as the covariate, was used to assess changes
over time between the two treatment groups in pain, func-
tion and other health related outcomes. The standard
deviation of the outcome variable was used to calculate
the sample size needed for a full scale trial using PS: Power
and Sample Size Calculation http://biostat.mc.vander
bilt.edu/twiki/bin/view/Main/PowerSampleSize.
Results
Recruitment rate and baseline data
From the database of one GP practice, 335 patients were
identified as potentially eligible to enter the trial. On
mailing these patients, 78 returned screening question-
naires and consent forms, and were found to be eligible
(see Figure 1.) The 40 people who responded most
promptly were sent the baseline questionnaire, on the
basis that they were most likely to complete the trial and
return questionnaires. Of the 40 patients who were sent
the questionnaire, 36 people returned their forms. The
first 30 patients to reply were selected and randomised
into two groups: 'acupuncture and usual care' and 'usual
care'. The baseline data collected prior to randomization
are presented in Table 1.
Attendance levels and intervention data
Of the fifteen participants randomised, fourteen attended
136 appointments (90% of the 150 maximum). Treat-
ments were provided by four acupuncturists, usually on a
weekly basis. Twelve patients attended all 10 available ses-
sions. One participant discontinued treatment after 7 ses-
sions as she felt her knee was very sensitive and did not
feel there was any improvement. A second participant dis-
continued treatment after 9 sessions because she felt that
the acupuncture treatment had been sufficiently success-
ful. The acupuncturists used theoretical frameworks that
included Channel Theory (14/14), Qi & Blood and BodyBMC Musculoskeletal Disorders 2009, 10:130 http://www.biomedcentral.com/1471-2474/10/130
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Table 1: Baseline Characteristics of Patients
Characteristics Acupuncture Control Total
Mean Age 62.9 (8.0) 64.2 (8.5) 63.5 (8.2)
Female Sex (%) 9 (60) 9 (60) 18 (60)
Ethnicity (%) White 15 (100) 15(100) 30(100)
Employment History (%)
Employed part-time 0 (0) 1 (7) 1 (3.3)
Employed full-time 6 (40) 2 (13) 8 (27)
Self employed 1 (6.9) 0 (0) 1 (3.3)
Retired 7 (47) 11 (73) 18 (60)
Not employed but seeking work 1 (6.9) 0 (0) 1 (3.3)
Not employed/not seeking work due to ill health 0 (0) 1 (7) 1 (3.3)
Education
Not in full time education (%) 15 (100) 15 (100) 30 (100)
Age when leaving full time education (SD) 18.1 (7.4) 15.5 (1.3) 16.8 (5.4)
Since leaving school/college/uni have had more part-time further/
higher education (%)
7 (47%) 4 (27%) 11 (37%)
Mean OKS (SD) 30.93 (9.32) 30.6 (9.30) 30.77 (9.15)
Mean WOMAC Scores (SD)
Pain 0-20 7.33 (2.82) 7.40 (3.66) 7.37 (3.21)
Stiffness 0-8 3.13 (1.46) 3.8 (1.57) 3.47 (1.53)
Function 0-68 20.53 (12.71) 26.27 (13.98) 23.4 (13.45)
Global 0-96
0 = best health
31 (15.65) 37.47 (18.18) 34.23 (16.99)
Mean SF36 Scores (SD)
Physical Functioning 49.59 (26.57) 48.33 (24.54) 48.96 (25.14)
Social Functioning 71.76 (25.21) 70 (23.53) 70.83 (23.97)
Role Physical Functioning 62.5 (28.35) 52.92 (25.43) 57.71 (26.9)
Role Mental Functioning 76.67 (26.01) 68.89 (35.56) 72.78 (30.87)
Mental Health 76.33 (15.41) 69.33 (18.7) 72.83 (17.21)
Vitality 55 (18.63) 46.25 (23.95) 50.63 (21.55)BMC Musculoskeletal Disorders 2009, 10:130 http://www.biomedcentral.com/1471-2474/10/130
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Fluids (12/14), Zang-fu Syndromes (8/14) and Patho-
genic Factors (7/14). The number of acu-points used in
each treatment session ranged from 4 to 24, with a mean
of 12. The most frequently used points were SP 6, 9, and
10; ST 36; LIV 3 and 8; LI 4; GB 34 and 41; KID 6; SJ 5; and
the extra point Xiyan. Stainless steel needles were used
with a diameter varying from 0.2 mm to 0.28 mm, length
from 25 mm to 50 mm, and depth of insertion from 3
mm to 30 mm. De qi was usually elicited, and a variety of
stimulation methods were used, including tonification
and reduction. Retention time for the needles varied from
10 to 30 minutes. Auxiliary treatments of moxibustion (3/
14) and acupressure massage (3/14) were provided. Life-
style advice was offered to 11 out of 14 patients and most
commonly in relation to relaxation (8/14), diet (6/14)
and exercise (6/14 times).
Data on usual care are presented in Table 2, which shows
that GP and physiotherapy consultations were the most
common type of additional healthcare, and medication
and walking aid use remained at an equivalent level
between groups and over time.
Outcomes measured at 3 and 12 months
The outcomes for the WOMAC, OKS, SF-36 and EQ-5D at
3 and 12 months, with mean scores and SD, are shown in
Table 3. The results (including 1 month data) are dis-
played in Figures 2 and 3 for the mean WOMAC pain and
global scores. Adjusted differences in outcome using a
regression model are shown in Table 4. Although the trial
was not powered to detect significant changes in outcome,
the WOMAC pain index showed a significant reduction [-
2.62 (95% CI: -0.77 to -4.47)] at 3 months in the acu-
puncture group compared to usual care. This was not sus-
tained at 12 months. No significant differences were
observed on the OKS scale or the domains of the SF-36.
Loss to follow up
The loss to follow up in the 'acupuncture plus usual care'
group was 0% at 3 months (n = 0) and 13.3% at 12
months (n = 2). It was higher in the 'usual care' group, at
6.7% at 3 months (n = 1) and 46.7% at 12 months (n =
7). We failed to send out reminders at the follow-up at
twelve months.
Adverse Events
No major adverse events were reported. Seven minor
adverse events were reported (Table 5). The seven events
out of a total of 136 treatments equate to adverse events
occurring in 5.2% of treatments. No patients discontin-
ued treatment as a consequence of adverse events.
Trial sample size and primary care list size for a fully 
powered trial
The WOMAC measure was chosen as the primary out-
come for the sample size calculation for the full scale trial
because it showed more sensitivity to change in this
patient group than the OKS. We know from a previous
study that an effect size of 0.39 on the WOMAC pain scale
or 0.37 on the WOMAC function scale is needed to detect
a minimally important change[24] We have selected the
WOMAC pain sub-scale as our primary measure because
of potential discordance in pain and function and because
the overlap on the pain and function sub-scales may play
a causal role in limiting the ability of the WOMAC func-
tion subscale to detect change[25] The mean square of the
residual variance of the WOMAC pain score was found
from our regression model to be 5.8, which can be con-
verted to a standard deviation of 2.4. Given a minimum
clinically important effect size of 0.39, the sample size
required to detect this difference at 5% significance and
90% power is 139 patients in each arm of a two-arm trial.
To allow for loss to follow up of 20%, a full-scale trial will
require 350 patients in total.
Our evidence suggests that we should introduce a mini-
mum WOMAC score of > or = 4 and at least 2 activities
with at least moderate pain[26]. This will impact on our
predicted recruitment rates, as only 63% (i.e. 49 patients
out of the 78) of patients in this pilot met this cut-off
score. Our GP practice had a registered list size of 15,900,
therefore we estimate that to recruit 350 patients we will
need a total primary care list size of approximately
115,000 patients.
Discussion
Key Findings
This pilot study has met key objectives by helping us iden-
tify useful information to assist the design of a full scale
acupuncture trial for osteoarthritis of the knee. With
regard to recruitment rate, we found that 23% of patients
identified on a York-based GP database as eligible agreed
to be recruited to the trial. With regard to outcome meas-
ures, we found the WOMAC scale to be more sensitive to
change in this patient group than the OKS scale. Attend-
ance at acupuncture sessions was high, with patients tak-
Pain 53.07 (18.71) 51.33 (24.31) 52.17 (21.42)
General Health 67.27 (16.95) 55.05 (19.03) 61.16 (18.76)
EQ5D (SD) 0.61 (0.24) 0.67 (0.15) 0.64 (0.2)
Table 1: Baseline Characteristics of Patients (Continued)BMC Musculoskeletal Disorders 2009, 10:130 http://www.biomedcentral.com/1471-2474/10/130
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Flow chart displaying details of eligible patients Figure 1
Flow chart displaying details of eligible patients.
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ing up on average 9 out of the 10 sessions available. We
had a very poor (46%) loss to follow-up at 12 months,
which is an area that will need better managing in a fully
powered trial. We calculated that a sample size of 350
would be required to detect clinically relevant differences
in this population.
Although the trial was not powered to detect significant
changes in outcome, the WOMAC pain index showed a
significant difference in favour of the acupuncture group
at 3 months but this was not sustained at 12 months.
Though no significant differences were observed in
WOMAC function, stiffness or global scores, nor in the
OKS, the trend was towards favouring acupuncture. The
size of any difference may have been more accurately
assessed if we had introduced a minimum baseline score
for knee pain when screening for eligibility. A single posi-
tive result within this pilot must be interpreted with cau-
tion, given the number of statistical tests conducted,
though it does reinforce the potential value of conducting
a full-scale study.
Table 2: Data on usual care at 3 and 12 months
Self reported health care received over preceding last 12 months
Location of consultations with health practitioners
Acupuncture Control
Reported at 3 
months n = 14
Reported at 12 
months n = 13
Reported at 3 
months n = 14
Reported at 12 
months n = 8
GP surgery
G P 3963
Nurse 0 1 0 0
Physiotherapist 2 0 3 0
Other 4 0 0 2
NHS hospital
G P 2002
Nurse 0 0 0 0
Physiotherapist 3 0 5 0
Other 0 0 0 0
Private health care professionals
G P 0400
Nurse 0 0 0 0
Physiotherapist 2 0 0 3
Self reported use of walking aids for knee and medication use over the last 12 months
Number who have used a walking aid for 
knee
5543
Number who have used medication for knee 7 7 8 4BMC Musculoskeletal Disorders 2009, 10:130 http://www.biomedcentral.com/1471-2474/10/130
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Table 3: Outcomes at three and twelve months
Acupuncture Control
OUTCOMES AT THREE MONTHS
Mean OKS (SD) 23.07 (6.54) 26.07 (10.91)
Mean WOMAC Scores (SD)
Pain 3.6 (2.92) 6.57 (4.54)
Stiffness 2.2 (1.78) 3.29 (1.86)
Function 13.4 (12.12) 21.86 (11.99)
Global 19.2 (16.52) 31.71 (17.5)
Mean SF36 Scores (SD)
Physical Functioning 60 (27.97) 52.14 (20.16)
Social Functioning 78.33 (25.65) 71.43 (24.72)
Role Physical Functioning 63.33 (28.63) 53.57 (29.08)
Role Mental Functioning 76.11 (26.7) 76.79 (24.06)
Mental Health 75 (14.64) 70 (21.99)
Vitality 61.67 (18.13) 49.52 (17.01)
Pain 68.93 (24.01) 59.57 (24.63)
General Health 71.33 (18.62) 58.62 (21.27)
EQ5D (mean) 0.71 (0.26) 0.66 (0.25)
OUTCOMES AT TWELVE MONTHS
Mean OKS (SD) 24.5 (7.5) 28.1 (9)
Mean WOMAC Scores (SD)
Pain 4.7 (2.3) 5.3 (3.9)
Stiffness 2.7 (1.6) 2.8 (1.6)
Function 17.4 (13.9) 17.6 (12.6)
Global 24.8 (17.1) 25.6 (17.6)
Mean SF36 Scores (SD)
Physical Functioning 54.2 (29.5) 55.6 (24.9)
Social Functioning 81.3 (20.3) 76.6 (20.5)
Role Physical Functioning 71.4 (25.21) 57.8 (27.9)BMC Musculoskeletal Disorders 2009, 10:130 http://www.biomedcentral.com/1471-2474/10/130
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Comparisons with other studies
Our evidence is consistent with other studies that com-
pared acupuncture to usual care for OA of the knee in
which short term benefits at the end of treatment
appeared to 'wear off' over time, including for example
data from a meta-analysis[10] and from a large scale trial
with a similar design from Germany[27] This pattern for
OA of the knee is not consistent with recent primary care
trials in the UK of acupuncture for headache over 12
months [13] and for low back pain over 24 months [14],
which both showed increasing statistical and clinical dif-
ferences between groups over the longer term. The reason
for this may be that osteoarthritis of the knee is a progres-
sive disease, whereas headache and back pain could be
more likely to fully remit between episodes. However
there remains a need for more primary data on the trajec-
tory of changes in outcome over the longer term, a point
emphasised by the recent NICE guidance and its associ-
ated recommendations[1]
Limitations and strengths of study
The attrition rate was higher at 12 months than would be
acceptable in a full scale trial, the reason being that no fol-
low-up requests were made to those who did not respond
to the initial request. For this pilot therefore, we have less
confidence in the results at 12 months. For a full scale
trial, it is recommended that a more systematic approach
to collecting patient outcome data be put in place, includ-
ing follow-up reminders and possibly financial incentives
in the form of a voucher or payment to patients. We also
note that by selecting the first patients to respond to our
invitations, we recruited the more eager volunteers. This
group may have higher adherence and follow-up rates
than may be present in the primary care population.
Patient preference was not taken into account, and
because it is likely that patients entered the trial with a
preference, those allocated to usual care may have been
more negative about their experience than those allocated
Role Mental Functioning 79.2 (26.95) 67.7 (18.6)
Mental Health 73.1 (17.02) 65.0 (19.1)
Vitality 58.2 (13.11) 46.9 (17.4)
Pain 65.2 (22.3) 65.9 (17.3)
General Health 67.7 (18.7) 62.4 (4.2)
EQ5D (mean) 0.66 (0.24) 0.63 (0.19)
Table 3: Outcomes at three and twelve months (Continued)
Table 4: Adjusted differences in WOMAC scores comparing acupuncture to usual care at 3 and 12 months, using a regression model 
with baseline WOMAC score as a covariate
WOMAC Index Month Adjusted means Adjusted difference 95% CI P value
Acupuncture Control
Pain 3 3.77 6.39 -2.62 -0.77 to -4.47 0.007
12 4.38 5.76 -1.38 0.8 to -3.56 0.200
Stiffness 3 2.49 2.98 -0.49 0.56 to -1.54 0.346
12 2.69 2.75 -0.58 1.3 to -1.4 0.930
Function 3 15.55 19.49 -3.94 3.4 to -11.3 0.281
12 16.81 18.18 -1.36 8.7 to -11.4 0.778
Global 3 22.27 28.43 -6.17 3.1 to -15.4 0.184
12 23.83 26.78 -2.94 9.5 to -15.4 0.624BMC Musculoskeletal Disorders 2009, 10:130 http://www.biomedcentral.com/1471-2474/10/130
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to acupuncture. This may have biased the outcome in
favor of the acupuncture group. However as the group
sizes were very small the interpretation of these data are
limited.
The pragmatic trial design is by necessity an open one. As
a result, this trial does not answer the question as to the
extent that the overall outcome was due to the 'specific
components' of the intervention, or to the 'non-specific
components', such as expectations of acupuncture. For
this question, an explanatory trial design would be appro-
priate. However the cost would be the reduced applicabil-
ity of the results to the general population of patients
within primary care. Secondary gains of a pragmatic trial
design for a full scale trial is that it can address the area of
cost-effectiveness and provide relevant data for decision-
making, whether by patients, service providers or policy
makers. This pilot was based in one GP practice and one
acupuncture clinic and therefore the results should be
interpreted with caution.
Future Research
There is a clear need for a full scale randomised controlled
trial to confirm and extend the applicability of the tenta-
tive findings from this pilot at three months. There have
been calls to establish whether any putative benefits at
three months are sustained over the longer term. Monitor-
ing patients in a trial over twelve months would help
answer this question, as well as provide more robust data
on cost- effectiveness, which would help reduce the dearth
of UK related data as reported by NICE[1] To this end we
recommend that resource use data associated with usual
care be collected every three months, to reduce vulnerabil-
ity to under-reporting. It would be worth considering
other sources of data beyond self-reports, such as GP
records for medication data. As part of "usual care", it
would also be useful to capture the extent that "core"
treatments, as proposed by NICE, such as advice and edu-
cation, weight loss and exercise, are taken up. Our tenta-
tive findings seem to show that the effects of acupuncture
might not carry-over beyond the end of treatment. If so,
then it might be worth considering a trial design that
includes the option of patients who have benefited receiv-
ing further top-up sessions after three months. A further
dimension to this area of research is the need to explore
any impact of acupuncture on quality of life. A new scale
to measure quality of life in this population has recently
been developed[20], and we recommend its use alongside
the WOMAC index in a full-scale trial. Another area we
suggest is monitored in a trial, which was identified by the
Graph displaying Mean WOMAC Pain Scores (range 0 to 20) Figure 2
Graph displaying Mean WOMAC Pain Scores (range 0 to 20).BMC Musculoskeletal Disorders 2009, 10:130 http://www.biomedcentral.com/1471-2474/10/130
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NICE guidance as highly relevant to this patient group, is
the impact of co-morbidities, such as anxiety and depres-
sion, that may compound the experience of osteoarthri-
tis[1] There is a need to explore more fully the
acceptability of acupuncture in this over 50s age group for
which in-depth interviewing is probably the method of
choice. Qualitative methods would also be useful in
exploring the trajectory of recovery for patients with this
condition.
Graph displaying Mean WOMAC Global Scores (range 0 to 96) Figure 3
Graph displaying Mean WOMAC Global Scores (range 0 to 96).
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Table 5: Minor adverse events reported by patients in the acupuncture group
Type of acupuncture - related minor adverse event reported Number of events Did the patient discontinue treatment?
Feeling faint 1 No
Unacceptable bruising 1 No
Worsening of existing symptoms with subsequent improvement 1 No
Worsening of existing symptoms with no subsequent improvement 1 No
Forgotten needle 1 No
Migraine 1 No
Pain at needle site 1 NoBMC Musculoskeletal Disorders 2009, 10:130 http://www.biomedcentral.com/1471-2474/10/130
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Conclusion
This study has shown that it is feasible to recruit patients
to a primary care trial to receive acupuncture for osteoar-
thritis of the knee, and that the tentative findings support
conducting a full-scale trial. The pilot data have led to an
estimate of the sample required for a full scale trial as well
as the expected recruitment rates. Recommendations have
been made to assist in the design, with the emphasis on
the need for data on longer term follow up, cost-effective-
ness, quality of life, as well as the collection of qualitative
data on acceptability and the trajectory of recovery in this
patient group.
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